Redondo E, Rivero-Calle I, Mascarós E, Yuste J E, Fernández-Prada M, Ocaña D, Jimeno I, Gil A, Molina J, Díaz-Maroto J L, Linares M, Martinón-Torres F
Medicina de Familia, Grupo de Actividades Preventivas y Salud Pública SEMERGEN, Centro de Salud Internacional, Ayuntamiento de Madrid, Madrid, España.
Servicio de Pediatría, Sección de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario, Santiago de Compostela, A Coruña, España; Genética Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, A Coruña, España.
Semergen. 2021 Sep;47(6):411-425. doi: 10.1016/j.semerg.2021.06.005. Epub 2021 Jul 29.
Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the practical prevention guide for CAP through vaccination in Spain developed in 2016 and updated in 2018, based on available vaccines and evidence through bibliographic review and expert opinion. The arrival of COVID-19 as a new cause of CAP and the recent availability of safe and effective vaccines constitutes the most significant change. Vaccines against pneumococcus, influenza, pertussis and COVID-19 can help to reduce the burden of disease from CAP and its associated complications. The available evidence supports the priority indications established in this guide, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice.
社区获得性肺炎(CAP)仍然是成人发病和死亡的重要原因。本研究的目的是根据现有疫苗以及通过文献综述和专家意见获得的证据,更新2016年制定并于2018年更新的西班牙CAP疫苗接种实用预防指南。新型冠状病毒肺炎(COVID-19)作为CAP的新病因出现以及近期安全有效疫苗的问世是最重大的变化。针对肺炎球菌、流感、百日咳和COVID-19的疫苗有助于减轻CAP及其相关并发症的疾病负担。现有证据支持本指南中确立的优先指征,建议在常规临床实践中努力广泛传播和实施这些建议。